EPAX changes hands again
This article was originally published in The Tan Sheet
Executive SummaryTrygg Pharma acquires the omega-3 oils firm from Austevoll Seafood and promises to open new opportunities and markets for EPAX. Aalesund, Norway-based EPAX also will significantly expand its manufacturing operations under Trygg, which is jointly owned by New York investment fund Lindsay Goldberg and krill product developer Aker BioMarine. EPAX Managing Director Bjorn Refsum said Sept. 3 the "ownership change will be a great benefit to our customers and ensure further progress in the omega-3 field." Austevoll acquired EPAX in January 2007 from Ferd Private Equity Fund (1"The Tan Sheet" Jan. 1, 2007, In Brief)
You may also be interested in...
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.